Alternations involving CRLF2 and their impact on STAT5 can induce cytokine-independent survival and proliferation of early hematopoietic cells, potentially contributing to the development of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) [45]. This evidence concerns the gene STAT5B and acute lymphoblastic leukemia.